Medtronic (MDT) Rating Dropped to Sell

Portfolio Grader currently ranks Medtronic Plc (NYSE:MDT) a Sell. The methodology for investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. MDT has been downgraded from a Hold to a Sell in the last week.

The company is one of 162 companies within the Health Care Equipment & Supplies GICS industry group, which is in turn part of the 782 company GICS Health Care sector. MDT has a market value of $107.5 billion which is in the top decile in its industry group The current Portfolio Grader ranking for MDT puts it 104 among the 162 companies in this industry group, which is a below-average position.

Portfolio Grader currently ranks the Health Care sector number 9 among the 12 sectors in its universe putting it in the bottom quartile of all the GICS sectors. The Health Care Equipment & Supplies industry group is ranked 38 among the 69 industry groups within the GICS sectors, placing it below-average in terms of the Navellier scoring system.

The scores the company has realized are average or below-average scores in 6 of the 8 areas analyzed by Portfolio Grader in the ranking of company stocks.

MDT's operational scores provide mixed results with rankings for operating margin and earnings growth that are above average, while the score for sales growth is below average. Scores for visibility of earnings are worse than the industry norms for earnings revisions, earnings surprises, and earnings momentum. MDT's scores for return on equity and cash flow are worse than its industry group average. These fundamental scores give Medtronic a position in the third quartile of the industry group.

The Navellier Proprietary Quantitative Score is used by Portfolio Grader to gauge MDT's shares from the angle of risk/reward. This exclusive scoring system takes into account the relative value of the company's shares based on the current price of the shares relative to its peers, the market and risk associated with its industry and sector groups. Using this risk/reward calculation, MDT currently scores below-average in its industry group compared to its peers.

Louis Navellier's proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results, with A being 'strong buy' and F being 'strong sell'. Explore the tool here.

Commentary provided by UpTick Data Technologies.


Article printed from InvestorPlace Media, https://investorplace.com/2017/11/medtronic-mdt-rating-dropped-to-sell/.

©2026 InvestorPlace Media, LLC